ストックスクリーナーアプリを入手
14.07
2.36%
-0.34
Novocure Ltd (NVCR) 最新ニュース
NovoCure (NVCR) Stock Looks Cheap On Sales But Weak On Adoption Risk - simplywall.st
NovoCure (NASDAQ: NVCR) Announces Board Vacancy Following Timothy Scannell's Departure on September 2, 2026 - Kalkine Media
NovoCure at Wells Fargo healthcare conference: launch momentum builds By Investing.com - Investing.com South Africa
NovoCure at Wells Fargo healthcare conference: launch momentum builds - Investing.com
NovoCure at Wells Fargo healthcare conference: launch momentum builds By Investing.com - Investing.com India
NovoCure at Wells Fargo healthcare conference: launch momentum builds By Investing.com - Investing.com UK
Novocure Ltd Announces Retirement of Timothy Scannell from the Board, Effective September 2, 2026 - marketscreener.com
Timothy Scannell retires from NovoCure board, seat vacated Sept 2, 2026 - TradingView
NovoCure (NASDAQ: NVCR) director steps down with no dispute - Stock Titan
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Yahoo Finance
NOVOCURE LTD (NVCR) Stock Chart - ChartMill
Cash flow from operating activities of NovoCure Ltd. – HAM:038 - TradingView
Net debt of NovoCure Ltd. – HAM:038 - TradingView
NovoCure says cyberattack caused patient data exposure - Yahoo Finance
Basic earnings per share (basic EPS) of NovoCure Ltd. – HAM:038 - TradingView
NovoCure (NVCR) Stock May Be Cheap Based On Sales Growth Risk - simplywall.st
NewsNovocure discloses cyberattack exposing records of more than 1,400 US cancer patients - teiss
Novocure Announces Upcoming Investor Events - finance.yahoo.com
NovoCure (NASDAQ: NVCR) Data Breach Exposes IDs Linked to Over 1,400 U.S. Patient Records - Kalkine Media
Novocure Reveals Major Breach of Cancer Patient Records - sqmagazine.co.uk
Oncology firm Novocure says cyberattack exposed US patient records - CNA
NVCR Looks 3.4% Undervalued on GF Value™ Amid Cybersecurity Inci - GuruFocus
Novocure reports data access affecting patient IDs for 1,400+ U.S. records; no device access - TradingView
NovoCure cyber breach hits 1,400+ patient records - Stock Titan
Is NovoCure (NVCR) A Bargain On Rising Earnings Estimates? - simplywall.st
NovoCure Limited (NVCR) Stock Price & News - Syfe
Novocure Ltd (NVCR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Wall Street Analysts See a 50.86% Upside in NovoCure (NVCR): Can the Stock Really Move This High? - Yahoo Finance
Novocure Ltd (NVCR) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Should NovoCure’s (NVCR) Upgraded Momentum Score and Earnings Revisions Require Action From Investors? - simplywall.st
A Look at NovoCure Ltd (NVCR) After 3.7% Decline -- GF Value $18 - GuruFocus
NovoCure (NASDAQ:NVCR) Shares Down 4%What's Next? - MarketBeat
Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice - Yahoo Finance
Novocure | 8-K: Current report - Moomoo
What’s Behind NovoCure (NVCR) Shares Climbing Today? - simplywall.st
What’s Behind NovoCure (NVCR) Shares Climbing Today? - simplywall.st
NVCR Q2 2026 Earnings: Loss Narrower Than Expected; Shares Slip 0.82Earnings Preview - vinanet.vn
Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet - Yahoo Finance
NovoCure (NVCR) Is Up 8.5% After Advancing Tumor Treating Fields Pipeline And Trials ProgressHas The Bull Case Changed? - simplywall.st
NovoCure (NVCR) Is Up 8.5% After Advancing Tumor Treating Fields Pipeline And Trials ProgressHas The Bull Case Changed? - simplywall.st
First Trust Advisors LP Invests $1.03 Million in NovoCure Limited $NVCR - marketbeat.com
NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued - simplywall.st
NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued - simplywall.st
NovoCure (NASDAQ:NVCR) Rating Increased to Buy at Wall Street Zen - MarketBeat
Novocure Ltd (NVCR) Stock Analysis & Forecast - TradingKey
NovoCure Ltd (038.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Quantinno Capital Management LP Has $27.11 Million Stock Position in NovoCure Limited $NVCR - MarketBeat
Novocure Stock Price Forecast. Should You Buy NVCR? - StockInvest.us
NovoCure (NVCR) Stock Looks Undervalued With Shares Down 90% Over Five Years - simplywall.st
4.30%
大文字化:
|
ボリューム (24 時間):